Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care and Improve Patient Outcomes


SAN FRANCISCO, October 20, 2021 /PRNewswire/ — Verana Health today announced the introduction of VeraQ™, a population health data engine that connects the dots between unfiltered health data with integrity to advance the quality of information for researchers. VeraQ is clinician-led and artificial intelligence (AI)-enhanced to securely power a data integrity feedback loop of nearly half a billion raw healthcare encounters at the point-of-care . Ultimately, VeraQ enables healthcare organizations and life science companies to accelerate medical innovations that promote quality of care for clinicians and quality of life for patients.

The VeraQ engine begins with anonymized electronic health record (EHR) data that is exclusively entrusted to Verana Health by more than 20,000 healthcare providers through specialty medical societies: the American Academy of Ophthalmology, the American Academy of Neurology (AAN) and the American Urological Association (AUA).

VeraQ connects and de-identifies rich outpatient data across multiple therapy areas, over 70 different EHR systems, and over 90 million patients with seven years of longitudinal data, while preserving the clinical context of point-of-care documentation health care providers. Then, structured and unstructured raw data is harmonized and symbolized between EHRs and medical specialties as well as other sources, such as medical claims, pharmaceutical claims, images, and mortality data. The anonymized data is then curated, protected, and curated using clinician supervision as well as natural language processing (NLP) and machine learning (ML).

The result is clinically true Q data™—disease-specific, purpose-fit data modules designed to confidently generate market intelligence and rigorously inform research results. Qdata covers three therapeutic areas – ophthalmology, neurology and urology – and reflects deep patient journeys through robust demographic data. Qdata helps unlock quality research information throughout the drug and medical device development lifecycle, from clinical trial site and subject identification to post-marketing evidence generation and research. opportunity analysis.

Qdata is particularly well suited to help answer complex research questions that require observational data traditionally found in doctors’ notes, which can include critical information such as symptoms, diagnoses, or outcomes. With VeraQ’s NLP-guided curation coupled with the human touch of physician-informed context, millions of records with free-form text become meaningful and can be distilled into usable and valuable Qdata variables.

“Health care begins and ends with the patient. Therefore, high-quality, accurate and reliable anonymized longitudinal patient data is essential to achieving the goal of producing impactful clinical research and positive health outcomes,” said Soujay JadhavCEO, Verana Health. “We are proud to launch VeraQ™ and Qdata™ to provide confidence in the integrity of information derived from unfiltered healthcare data to enable our life science partners to accelerate medical innovations and healthcare providers to health to improve the quality of care.

VeraQ also powers Qualified Clinical Data Registries (QCDRs) for Verana Health’s medical society partners, including the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight), AAN Axon Registry®, and AUA Quality Register (AQUA). For IRIS Registry and Axon Registry, it enables compliance with Merit-Based Incentive Payment System (MIPS) reporting standards, which are measures of quality of care required by the Centers for Medicare and Medicaid Services (CMS). Participation in a QCDR saves contributing medical practices thousands of dollars annually; in fact, the IRIS Registry has helped participating ophthalmologists save more than $1 billion penalties from 2017 to 2020.

Additionally, VeraQ enables practices to improve patient care by helping identify patients who may qualify for a clinical trial, which can accelerate trial activity for physician investigators and life science sponsors. life.

“Electronic health record data is the purest reflection of factors contributing to clinical outcomes and VeraQ brings value to healthcare providers by generating quality insights from this rich point-of-care data to help to inform their care,” Jadhav said. “The medical community can be confident that Verana Health handles anonymized clinical data with the same care and integrity that physicians provide to their patients.”

About Verana Health
Verana Health is a digital health data company that delivers insights from unfiltered health data with integrity to connect the dots between patient care and clinical research. Verana Health is exclusively trusted by key specialty medical companies to manage data for real-world healthcare environments across more than 20,000 healthcare providers and 70 electronic health record systems. Its health data ecosystem is powered by VeraQ™, a clinician-led, AI-enhanced population health data engine that securely powers a data integrity feedback loop of nearly half a billion raw point-of-care health encounters. By applying advanced analytics to proprietary and curated datasets, Qdata™, Verana Health helps life science collaborators improve evidence generation and accelerate medical innovations that drive quality of care and quality of life . For more information, visit

Media Contact
Megan Moriarty
Amendola Communications
E-mail: [email protected]
Cell: (913) 515-7530

SOURCE Verana Health


Comments are closed.